Business
Dechra Pharmaceuticals
Dechra Pharmaceuticals.
About this update from Persimmon Plc
Further to the FTSE notice released on 09 January 2024 in relation to Dechra Pharmaceuticals (UK): Constituent Deletion, please note the replacement in the fixed indices. All other details remain unchanged. Please see updated notice below: Dechra Pharmaceuticals (UK): Constituent Deletion - Update Changes in FTSE UK Index Series 11 January 2024 Subject to court sanctioning the scheme of arrangement in relation to the cash offer for Dechra Pharmaceuticals (UK, constituent) by Freya Bidco Limited (non-constituent), please see details of affected indexes and effective dates below: Dechra Pharmaceuticals (UK, 0963318) will be deleted from the index. Persimmon PLC (UK, 0682538) will be added to the FTSE 100 Index and deleted from the FTSE 250 Index. Baillie Gifford US Growth Trust (UK, BDFGHW4) will be added to the FTSE 250 Index and deleted from the FTSE SmallCap Index. All changes effective from 16 January 2024 Full details of index changes are available on the FTSE Russell website. For further information please contact FTSE Russell Client Services at [email protected] or call: Australia +61 (0) 2 7228 5659 Hong Kong +852 2164 3333 Japan +81 3 6441 1430 London +44 (0) 20 7866 1810 New York +1877 503 6437 Alternatively please visit our website at lseg.com/ftse-russell Terms of Use | Copyright © 2024 FTSE Russell